E25.9 ICD-10-CA code: Adrenogenital disorder, unspecified

E25.9 is the ICD-10-CA code for “Adrenogenital disorder, unspecified” in CIHI’s FY 2026–2027 release, in effect from Apr 1, 2026.

Official description

E25.9

Adrenogenital disorder, unspecified

Short description: Adrenogenital disorder unspecified

ICD-10-CA · Canada · Also written E259

Index terms

Entries in CIHI’s alphabetical index that lead to E25.9. Searching the index by the condition the note names is how coders reach this code.

  • Virilism (adrenal)
  • Virilization (female)
  • Adrenogenital syndrome
  • Syndrome, adrenogenital
  • Disorder (of), adrenogenital
  • Macrogenitosomia (adrenal) (male) (precox)
  • Masculinization (female) with adrenal hyperplasia
  • Hyperfunction, adrenal cortex, not associated with Cushing's syndrome, virilism
  • Hyperplasia, hyperplastic, adrenal (capsule) (cortex) (gland), with, virilism, adrenal
  • Hyperplasia, hyperplastic, adrenal (capsule) (cortex) (gland), with, virilization (female)
  • Hyperplasia, hyperplastic, adrenal (capsule) (cortex) (gland), with, sexual precocity (male)
  • Precocity, sexual (female) (male) (constitutional) (cryptogenic) (idiopathic) NEC, with adrenal hyperplasia

Notes for E25.9

As CIHI prints them, with any note E25.9 takes from the headings above it.

Includes

  • Adrenogenital syndrome NOS
  • Adrenogenital syndromes, virilizing or feminizing, whether acquired or due to adrenal hyperplasia consequent on inborn enzyme defects in hormone synthesisfemale:• adrenal pseudohermaphroditism• heterosexual precocious pseudopubertymale:• isosexual precocious pseudopuberty• macrogenitosomia praecox• sexual precocity with adrenal hyperplasiavirilization (female)From E25 Adrenogenital disorders

Excludes

Conditions classified elsewhere.

  • Galactorrhoea (N64.3)gynaecomastia (N62)From E20-E35 Disorders of other endocrine glands
  • Complications of pregnancy, childbirth and the puerperium (O00-O99)symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)transitory endocrine and metabolic disorders specific to fetus and newborn (P70-P74)From Chapter 4: Endocrine, nutritional and metabolic diseases (E00-E90)

Note

  • All neoplasms, whether functionally active or not, are classified in Chapter II. Appropriate codes in this chapter (i.e. E05.8)(E07.0) (E16-E31)(E34.-) may be used, if desired, as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.From Chapter 4: Endocrine, nutritional and metabolic diseases (E00-E90)

Where E25.9 sits

  1. 1ChapterChapter 4: Endocrine, nutritional and metabolic diseases (E00-E90)
  2. 2Block E20-E35Disorders of other endocrine glands
  3. 3Category E25Adrenogenital disorders
  4. 4Valid code E25.9Adrenogenital disorder, unspecified

Source and release

Data release
ICD-10-CA · FY 2026–2027
Effective date
Apr 1, 2026
Publisher
CIHI

This page is built from the ICD-10-CA catalog that Vero Codes reads when it suggests codes: Canadian Institute for Health Information’s FY 2026–2027 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does ICD-10-CA code E25.9 mean?

E25.9 is the ICD-10-CA code for “Adrenogenital disorder, unspecified” in CIHI’s ICD-10-CA FY 2026–2027 release.

Where is E25.9 in ICD-10-CA?

E25.9 sits under E25 Adrenogenital disorders, within E20-E35 Disorders of other endocrine glands, within Chapter 4: Endocrine, nutritional and metabolic diseases (E00-E90).

What coding notes apply to E25.9?

ICD-10-CA lists Includes, Excludes, Note notes for E25.9, including those from the headings it sits under. They are listed on this page with where each one comes from.

Which ICD-10-CA release does this page use?

It uses CIHI’s FY 2026–2027 release, in effect from Apr 1, 2026 to Mar 31, 2027. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.